RxDoctor Payments Data

Konark Malhotra, MD

Neurology · Pittsburgh, PANPI 1831479633

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $778 and has fallen 78.5% since, to $167 in 2022. That places this record below the midpoint for neurology clinicians in PA, where the typical reported total is $778.

$959in general payments, 2019–2025

Across 20 payments — averaging $47.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$193
  • Eisai Inc.$159
  • Viz.ai, Inc.$139
  • Greenwich Biosciences, Inc.$125
  • Novartis$115
  • Teva Pharmaceuticals USA, Inc.$79
  • plus $148 from 5 others

What the payments were for

  • Food & beverage$959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$959 in reported general payments places this provider in the 50th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$36,064
Medicare patients
156
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Divalproex Sodium13$272
Levetiracetam11$114

Paid to pharmacies, not to this prescriber.

Other neurology in Pittsburgh

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →